Drug Shortage Report for CARBOPLATIN INJECTION

Last updated on 2017-09-19 History
Report ID 10874
Drug Identification Number 02125439
Brand name CARBOPLATIN INJECTION
Common or Proper name CARBOPLATIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CARBOPLATIN
Strength(s) 10MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 45ML
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-18
Estimated end date 2017-07-27
Actual end date 2017-08-01
Shortage status Resolved
Updated date 2017-09-19
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-09-19 French Compare
v3 2017-09-19 English Compare
v2 2017-05-23 French Compare
v1 2017-05-23 English Compare